ArticleGland surgery2026
TILOOP mesh in immediate prepectoral breast reconstruction via single-port endoscopic axillary approach: a study in early- and mid-stage breast cancer patients.
Article in Gland surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prepectoral implant-based breast reconstruction (BR) via single-port endoscopic axillary approach reduces visible scarring and incision-related complications. TILOOP mesh may improve implant support and aesthetics, but its added value remains uncertain. This study evaluated outcomes, complications, and patient satisfaction with mesh use. Methods: A retrospective cohort of 383 patients (165 mesh Results: Baseline features were balanced. The mesh group showed slightly lower mean postoperative pain scores and higher breast satisfaction scores; however, these differences did not reach statistical significance (P>0.05). Mesh use was associated with greater blood loss (98.1±62.2 Conclusions: Mesh-assisted prepectoral reconstruction demonstrated comparable safety outcomes to non-mesh reconstruction, with a trend toward reduced postoperative pain and improved breast satisfaction but without statistically significant differences. Mesh use was associated with higher blood loss and longer hospitalization. Overall, mesh application should be individualized based on breast volume, reconstructive goals, and patient-specific factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.